NRSN - NeuroSense Therapeutics Ltd.

Stock Grade Analysis

General Rating

C
Overall Score: 2/5
Multi-dimensional Scores
DCF: 1/5 ROE: 5/5 ROA: 1/5 D/E: 1/5 P/E: 1/5
Financial Ratios Trend

Grades Consensus

0

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

Buy

Consensus

Grade News & Updates

Date Grading Company New Grade Previous Grade Action Price When Posted News Title Publisher
2026-09-03 H.C. Wainwright Buy N/A Initialise $0.4108 NeuroSense initiated with a Buy at H.C. Wainwright TheFly
2025-10-14 Noble Capital Markets Outperform N/A Initialise $1.225 NeuroSense initiated with an Outperform at Noble Capital TheFly